USE OF CHEST COMPUTED TOMOGRAPHY IN THE MANAGEMENT OF COVID-19: INTEGRATIVE LITERATURE REVIEW

Abstract

COVID-19 is an infectious disease that affects the lungs and was first detected in December 2019 in the city of Wuhan, China. Caused by the SARS-CoV-2 coronavirus, the disease spread rapidly. This study was guided by the following research question: what is the national and international scientific output regarding the use of chest CT in the management of COVID-19? Accordingly, an integrative literature review was conducted with the aim of investigating national and international scientific research on the use of chest computed tomography as a complementary diagnostic tool in the management of COVID-19. A total of 21 studies published between 2020 and 2024 were analyzed, sourced from the PUBMED, LILACS, and SCIELO virtual library databases. The studies analyzed, both nationally and internationally, demonstrate that chest CT is effective in detecting characteristic changes, making it a valuable tool for both aiding in diagnosis and monitoring disease progression.